GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (XCNQ:IAN) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

iAnthus Capital Holdings (XCNQ:IAN) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of May. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.


iAnthus Capital Holdings  (XCNQ:IAN) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

iAnthus Capital Holdings EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

iAnthus Capital Holdings (XCNQ:IAN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (XCNQ:IAN) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)
Comparable Companies
NEOE:CBST XCNQ:EPIC TSX:ACB XCNQ:FFNT XCNQ:AAWH.U XCNQ:PLTH TSX:HLS TSX:OGI XCNQ:AYR.A XCNQ:JUSH ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ITHUF:USA 2IA:Germany
Address
420 Lexington Avenue, Suite 414, New York, NY, USA, 10170
Website
https://www.ianthus.com
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Hadley Ford Director, Senior Officer

iAnthus Capital Holdings (XCNQ:IAN) Headlines

No Headlines